Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study
- 11 November 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 32 (2), 411-423
- https://doi.org/10.1681/asn.2020060848
Abstract
Background Case reports suggest an association between inflammatory bowel disease, a chronic autoimmune condition linked to increased circulating IgA levels, and IgA nephropathy, the most common form of primary GN and a leading cause of ESKD. Methods In a Swedish population-based cohort study, we compared 3963 biopsy-verified IgA nephropathy patients with 19,978 matched controls between 1974 and 2011, following up participants until 2015. Inflammatory bowel disease data and ESKD status were obtained through national medical registers. We applied Cox regression to estimate hazard ratios (HRs) for future inflammatory bowel disease in IgA nephropathy and conditional logistic regression to assess risk of earlier inflammatory bowel disease in IgA nephropathy. We also explored whether inflammatory bowel disease affects development of ESKD in IgA nephropathy. Results During a median follow-up of 12.6 years, 196 (4.95%) patients with IgA nephropathy and 330 (1.65%) matched controls developed inflammatory bowel disease (adjusted HR, 3.29; 95% confidence interval [95% CI], 2.73 to 3.96). Inflammatory bowel disease also was more common before a confirmed IgA nephropathy diagnosis. Some 103 (2.53%) IgA nephropathy patients had an earlier inflammatory bowel disease diagnosis compared with 220 (1.09%) controls (odds ratio [OR], 2.37; 95% CI, 1.87 to 3.01). Both logistic regression (OR, 2.60; 95% CI, 2.02 to 3.35) and time-varying Cox regression (HR, 1.84; 95% CI, 1.33 to 2.55) demonstrated that inflammatory bowel disease was associated with increased ESKD risk in patients with IgA nephropathy. Conclusions Patients with IgA nephropathy have an increased risk of inflammatory bowel disease both before and after their nephropathy diagnosis. In addition, among patients with IgA nephropathy, comorbid inflammatory bowel disease elevates the risk of progression to ESKD.Keywords
Funding Information
- Region Värmland
This publication has 39 references indexed in Scilit:
- A case of rapidly progressive IgA nephropathy in a patient with exacerbation of Crohn’s diseaseBMC Nephrology, 2012
- Imbalance of regulatory T cells to Th17 cells in IgA nephropathyScandinavian Journal of Clinical and Laboratory Investigation, 2012
- External review and validation of the Swedish national inpatient registerBMC Public Health, 2011
- IgA nephropathy in association with Crohn's disease: a case report and brief review of the literatureRenal Failure, 2010
- The Swedish personal identity number: possibilities and pitfalls in healthcare and medical researchEuropean Journal of Epidemiology, 2009
- Immunoglobulin A Nephropathy and Ulcerative ColitisAmerican Journal of Nephrology, 2001
- Incidence of biopsy-proven primary glomerulonephritis in an Italian ProvinceAmerican Journal of Kidney Diseases, 1996
- Epidemiology of primary glomerular diseases in a French region. Variations according to period and ageKidney International, 1994
- Local IgA subclass alterations in ulcerative colitis and Crohn's disease of the colon.Gut, 1987
- Epidemiology of idiopathic glomerular disease: A prospective studyKidney International, 1987